AEMD

AETHLON MEDICAL INC AEMD

NasdaqSmall CapHealthcare

13F Pro Quality Score

Not in ranked universe

Below size threshold

Below the main board's size threshold of $25M annual revenue or $100M total assets. This company reported $1.6M in revenue and is scored on the micro-cap board instead.

Financial data, filings, and institutional holdings below are still tracked in full — only the proprietary quality composite is unavailable for this name.

Net income

$-1.55M

Quarter to Jun 30

Free cash flow

$-1.91M

Quarter to Jun 30

Top Institutional Holders

as of Q2 2026
$218.1K total
HRT FINANCIAL LP
$59.0KNew
CITADEL ADVISORS LLC
$35.4KNew
JANE STREET GROUP, LLC
$32.0KNew
Shay Capital LLC
$25.6K+120.0%
Virtu Financial LLC
$23.0KNew
Ikarian Capital, LLC
$11.8K0.0%
GEODE CAPITAL MANAGEMENT, LLC
$8.4K-58.2%
Scientech Research LLC
$8.3KNew
UBS Group AG
$7.3K+891.7%
Tower Research Capital LLC (TRC)
$5.2K+293.0%
MORGAN STANLEY
$2.0K+20.8%
JONES FINANCIAL COMPANIES LLLP
$15New
Integrated Wealth Concepts LLC
$12New
GROUP ONE TRADING, L.P.
$120.0%
BlackRock, Inc.
$80.0%
NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO
$2New
WELLS FARGO & COMPANY/MN
$20.0%
DANSKE BANK A/S
$10.0%
See all 18 institutional holders →
Reading the latest SEC filing…

Key Metrics

Net Income

Q1 2027
EDGAR

EPS (Diluted)

Q1 2027
EDGAR

Free Cash Flow

Q1 2027
EDGAR

Financial Trends

Revenue & Net Income

13fpro.ai/company/AEMD

Earnings Per Share

13fpro.ai/company/AEMD

Loading ratio trend…

AEMD key financials by period

Reported revenue, net income and operating margin by fiscal year, from AETHLON MEDICAL INC's annual filings on SEC EDGAR.

AETHLON MEDICAL INC reported revenue, net income and margins by fiscal period, from SEC filings.
PeriodRevenueNet incomeOp. margin
FY 2023$574.2K$-12.0M—
FY 2022$294.2K$-10.4M—
FY 2021$659.1K$-7.9M—
FY 2020$650.2K$-6.4M—
FY 2019$229.6K$-6.2M—
FY 2018$149.6K$-5.7M—
Source: AEMD filings on SEC EDGAR →

AEMD insiders

Officers, directors and 10% owners with a Form 4 filed in the last 24 months, most recent first. From SEC EDGAR.

About AETHLON MEDICAL INC (AEMD): stock profile, AI score and financials

AETHLON MEDICAL INC (AEMD) stock profile, AI quality score, and SEC EDGAR financial data, a Healthcare sector company. AEMD is not currently included in 13F Pro's AI-ranked quality universe — below the main board's size threshold of $25m annual revenue or $100m total assets. this company reported $1.6m in revenue and is scored on the micro-cap board instead. Based on the latest XBRL financial filings (Q1 2027), AETHLON MEDICAL INC reports net income of $-1.5M, free cash flow of $-1.9M. Top institutional holders of AEMD by reported 13-F value include HRT FINANCIAL, CITADEL ADVISORS, JANE STREET GROUP, based on the most recent SEC filings. AEMD trades on the Nasdaq exchange and files with the SEC under CIK 882291. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate AEMD daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for AETHLON MEDICAL INC directly from SEC EDGAR.

Financials through the period ended SEC EDGAR: CIK 882291 →